Neurofibromatosis type I in children: a case report and literature review.

Jing Wang, Yaqian Pang, Feng Cao, Hao Zhu, Kai Zhang

Open access · greenAbstract readCase Reports

In one paragraph

Article in International journal of clinical and experimental pathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it

0cells of the map it votes in

1citing papers in PubMed

–field-weighted citation impact, top 82% of its field

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 0 citations in OpenAlex.

Neurofibromin 1 (International journal of molecular sciences · 2026
Article

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Jing WangDepartment of Stomatology, The First Affiliated Hospital of Bengbu Medical College Bengbu 233004, Anhui, P. R. China.

Yaqian PangDepartment of Stomatology, The First Affiliated Hospital of Bengbu Medical College Bengbu 233004, Anhui, P. R. China.

Feng CaoDepartment of Stomatology, The First Affiliated Hospital of Bengbu Medical College Bengbu 233004, Anhui, P. R. China.

Hao ZhuDepartment of Stomatology, The First Affiliated Hospital of Bengbu Medical College Bengbu 233004, Anhui, P. R. China.

Kai ZhangDepartment of Stomatology, The First Affiliated Hospital of Bengbu Medical College Bengbu 233004, Anhui, P. R. China.

First Affiliated Hospital of Bengbu Medical College · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neurofibromatosis is an autosomal dominant genetic disease that originates from neuroepithelial tissue and involves disorders of ectoderm and mesoderm. At present, there are relatively few reports of neurofibroma type I in children. Therefore, understanding the clinical manifestations, diagnosis, and treatment of neurofibromatosis is of great significance to the occurrence and development of neurofibroma type I. This study is a case of and literature review of neurofibromatosis type I in children.

Indexed as

autosomal dominant hereditary diseaseliterature reviewNeurofibromatosis

Identifiers

PMID33165424

PMCPMC7642698

OpenAlexW3105033103

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.